Clinical Trial Update: Gene Therapy for Chronic Granulomatous Disease [Phase 1, Phase 2]

View source ↗

Summary

Update on a phase 1/2 clinical trial evaluating a gene therapy for chronic granulomatous disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Snippet

Sponsor: Johann Wolfgang Goethe University Hospital | Conditions: Granulomatous Disease, Chronic | Phase 1, Phase 2 | Status: UNKNOWN